Product
Bosutinib + Atezolizumab
1 clinical trial
1 indication
Indication
Chronic Myeloid LeukemiaClinical trial
Multicenter, Open-label, Phase Ib/II Trial to Evaluate Safety and Efficacy for the Combination of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Myeloid Leukemia PatientsStatus: Terminated, Estimated PCD: 2021-09-24